Show simple item record

dc.contributor.authorSeager, R J
dc.contributor.authorZaman, Muhammad H
dc.contributor.authorHajal, Cynthia
dc.contributor.authorSpill, Fabian
dc.contributor.authorKamm, Roger Dale
dc.date.accessioned2018-12-12T20:09:23Z
dc.date.available2018-12-12T20:09:23Z
dc.date.issued2017-07
dc.date.submitted2017-07
dc.identifier.issn2057-1739
dc.identifier.urihttp://hdl.handle.net/1721.1/119621
dc.description.abstractIn the tumour microenvironment, cancer cells directly interact with both the immune system and the stroma. It is firmly established that the immune system, historically believed to be a major part of the body's defence against tumour progression, can be reprogrammed by tumour cells to be ineffective, inactivated, or even acquire tumour promoting phenotypes. Likewise, stromal cells and extracellular matrix can also have pro-and anti-tumour properties. However, there is strong evidence that the stroma and immune system also directly interact, therefore creating a tripartite interaction that exists between cancer cells, immune cells and tumour stroma. This interaction contributes to the maintenance of a chronically inflamed tumour microenvironment with pro-tumorigenic immune phenotypes and facilitated metastatic dissemination. A comprehensive understanding of cancer in the context of dynamical interactions of the immune system and the tumour stroma is therefore required to truly understand the progression toward and past malignancy. Keywords: cancer; microenvironment; mechanical; extracellular matrix; macrophage; T cell; fibroblasten_US
dc.description.sponsorshipNational Cancer Institute (U.S.) (Grant U01 CA202177)en_US
dc.publisherIOP Publishingen_US
dc.relation.isversionofhttp://dx.doi.org/10.1088/2057-1739/AA7E86en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourcearXiven_US
dc.titleDynamic interplay between tumour, stroma and immune system can drive or prevent tumour progressionen_US
dc.typeArticleen_US
dc.identifier.citationSeager, R J et al. “Dynamic Interplay Between Tumour, Stroma and Immune System Can Drive or Prevent Tumour Progression.” Convergent Science Physical Oncology 3, 3 (July 2017): 034002 © 2017 IOP Publishing Ltden_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Mechanical Engineeringen_US
dc.contributor.mitauthorHajal, Cynthia
dc.contributor.mitauthorSpill, Fabian
dc.contributor.mitauthorKamm, Roger Dale
dc.relation.journalConvergent Science Physical Oncologyen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2018-12-05T17:59:08Z
dspace.orderedauthorsSeager, R J; Hajal, Cynthia; Spill, Fabian; Kamm, Roger D; Zaman, Muhammad Hen_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0001-8462-5080
dc.identifier.orcidhttps://orcid.org/0000-0002-7232-304X
mit.licenseOPEN_ACCESS_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record